It does seem like GC placed a new priority on Eltop in that blog. I'm also curious if the FDA would even grant "Fast Track" status given there are no drugs approved specifically for that indication and 700+ individuals have shown no safety issues.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links